ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 5 of 21 for:    Autism Spectrum Disorder | United Kingdom

The Use of Social Stories to Reduce Negative Affect and Improve Satisfaction in Adults Attending an ASD Assessment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03372421
Recruitment Status : Recruiting
First Posted : December 13, 2017
Last Update Posted : August 1, 2018
Sponsor:
Information provided by (Responsible Party):
Richard Jenkinson, University of Sheffield

Brief Summary:
Many people with Autism Spectrum Disorder (ASD) find the unpredictability of social situations emotionally distressing. It is likely that attending a diagnostic assessment is no exception. Social Stories are short stories that describe a social situation so that people know what to expect. They are written in a way that is accessible to people with ASD. This study will explore whether a Social Story written about a diagnostic assessment can reduce the associated emotional distress and increase people's satisfaction with the process. If so, they could be a simple way that services can better cater for their clients' needs.

Condition or disease Intervention/treatment Phase
Autism Spectrum Disorder Other: Social Story Other: Standard Information Not Applicable

  Show Detailed Description

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 62 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Masking Description: Participants will not be told whether they are in the experimental or control group.
Primary Purpose: Supportive Care
Official Title: The Use of Social Stories to Reduce Negative Affect and Improve Satisfaction in Adults Attending an Assessment for Autism Spectrum Disorder
Actual Study Start Date : May 26, 2018
Estimated Primary Completion Date : March 31, 2019
Estimated Study Completion Date : March 31, 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Social Story
Participants will read information about what to expect from the assessment in the format of a Social Story
Other: Social Story
A short story written in the third person about what it's like to attend an assessment for ASD.

Active Comparator: Standard Information
Participants will read standard information about what to expect from the assessment.
Other: Standard Information
Information the host site currently sends out to patients informing them about what to expect from the assessment




Primary Outcome Measures :
  1. Positive and Negative Affect Schedule [ Time Frame: Change scores: baseline and 3 weeks ]
    A widely used self-report measure of positive and negative affect with good psychometric properties (Crawford & Henry, 2004) and has been used in previous research to measure negative affect in people with ASD (Samson, Huber, & Gross, 2012).


Secondary Outcome Measures :
  1. Assessment Satisfaction [ Time Frame: 3 weeks ]
    Participants will be asked to rate their overall satisfaction with the diagnostic assessment, on a 5 point Likert scale.

  2. Predictability [ Time Frame: 3 weeks ]
    Participants will be asked to rate, on a 5 point Likert scale, to what extent the information they read prior to their assessment has thus far helped them to know what to expect from the assessment.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • People who are awaiting an ASD assessment at the host site.
  • People who have never visited the site before.

Exclusion Criteria:

  • People who do not receive a diagnosis of ASD following the study will not be included in the inferential statistical analysis. However, they will still be participants in the study and their data will be reported descriptively.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03372421


Contacts
Contact: Richard p Jenkinson (+44) 07886822479 rjenkinson2@sheffield.ac.uk
Contact: Elizabeth Milne (+44) 0114 22 26558 E.Milne@sheffield.ac.uk

Locations
United Kingdom
Sheffield Adult Autism and Neurodevelopmental Service Recruiting
Sheffield, South Yorkshire, United Kingdom, S11 9BF
Contact: Richard Smith, DClinPsy    0114 2716964      
Sponsors and Collaborators
University of Sheffield
Investigators
Principal Investigator: Richard p Jenkinson University of Sheffield

Additional Information:
Responsible Party: Richard Jenkinson, Trainee Clinical Psychologist, University of Sheffield
ClinicalTrials.gov Identifier: NCT03372421     History of Changes
Other Study ID Numbers: rjenkinson001
First Posted: December 13, 2017    Key Record Dates
Last Update Posted: August 1, 2018
Last Verified: July 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: Individual data will not be shared in order to protect the participants' confidentiality

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Autism Spectrum Disorder
Child Development Disorders, Pervasive
Neurodevelopmental Disorders
Mental Disorders